Atrás
Rango del Día
$84.71
$88.32
Rango de 52 Semanas
$36.36
$120.74
Volumen
1,506,773
Promedio 50D / 200D
$101.84
/
$78.08
Cierre Anterior
$85.18
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -26.8 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -42.4 | 3.8 |
| Rev Growth 5Y % | 27.3 | 10.0 |
| D/E | — | 0.2 |
Puntos Clave
Revenue grew 27.32% annually over 5 years — strong growth
Negative free cash flow of -233.07M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.56%
Capital efficient — spends only 4.92% of revenue on capex
Crecimiento
Revenue Growth (5Y)
27.32%
Revenue (1Y)32.88%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
N/A
ROIC-20.67%
Net Margin-42.39%
Op. Margin-44.43%
Seguridad
Debt / Equity
N/A
Current Ratio4.84
Interest Coverage-111.96
Valoración
P/E Ratio
-26.77
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 32.88% | Revenue Growth (3Y) | 31.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 27.32% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 982.02M | Net Income (TTM) | -416.28M |
| ROE | N/A | ROA | -20.67% |
| Gross Margin | 64.46% | Operating Margin | -44.43% |
| Net Margin | -42.39% | Free Cash Flow (TTM) | -233.07M |
| ROIC | -20.67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 4.84 |
| Interest Coverage | -111.96 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -26.77 | P/B Ratio | N/A |
| P/S Ratio | 11.35 | PEG Ratio | 4.56 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 11.14B | Enterprise Value | 12.45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 982.02M | 739.02M | 563.95M | 449.54M | 373.65M |
| Net Income | -416.28M | -436.37M | -479.45M | -654.59M | -405.67M |
| EPS (Diluted) | -3.32 | -3.56 | -4.28 | -6.41 | -3.80 |
| Gross Profit | 633.01M | 449.22M | 336.90M | 293.21M | 250.74M |
| Operating Income | -436.30M | -443.59M | -564.73M | -544.38M | -411.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.01B | 1.49B | 1.79B | 1.61B | 2.20B |
| Total Liabilities | 2.11B | 1.63B | 1.63B | 1.55B | 1.56B |
| Shareholders' Equity | -99.31M | -139.65M | 158.68M | 60.18M | 645.01M |
| Total Debt | 1.68B | 1.34B | 1.35B | 1.37B | 1.37B |
| Cash & Equivalents | 378.20M | 525.54M | 1.13B | 141.65M | 492.20M |
| Current Assets | 1.47B | 1.06B | 1.35B | 1.19B | 1.11B |
| Current Liabilities | 302.73M | 225.58M | 205.92M | 193.22M | 194.69M |